惠生國際(01340.HK)子公司獲壁管系統分銷權
惠生國際(01340.HK)公布,在去年第四季,公司通過其間接非全資子公司開展了銷售和分銷管道系統產品的新業務,此外,該運營公司還將提供有關該管道系統的設計、應用、實施和安裝的技術諮詢服務的新業務。在過去幾個月中,運營公司一直與一所德國公司(許可方)商討有關獲得分銷權之事宜。該許可方專門從事柔性壁管系統的製造、推廣及銷售,壁管系統的最大優勢在於內管由波紋不銹鋼製成,並具有外部防腐蝕保護層,可用於工業應用、建造業及互聯網和數據基礎架構。
目前,許可方已將該分銷權授予運營公司。集團擬以其內部資源為新業務提供資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.